Sanara MedTech Inc. (SMTI)
| Bid | 24 |
| Market Cap | 261M |
| Revenue (ttm) | 86.67M |
| Net Income (ttm) | -9.66M |
| EPS (ttm) | -1.14 |
| PE Ratio (ttm) | -25.72 |
| Forward PE | -12.17 |
| Analyst | Strong Buy |
| Ask | 30 |
| Volume | 36,725 |
| Avg. Volume (20D) | 27,336 |
| Open | 28.67 |
| Previous Close | 28.69 |
| Day's Range | 28.20 - 29.45 |
| 52-Week Range | 25.86 - 39.08 |
| Beta | 1.47 |
About SMTI
Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako's Antimicrobial Skin and Wound Cleanser, a patented product that disrupts extracellular polymeric substances to eradicate matur...
Analyst Forecast
According to 2 analyst ratings, the average rating for SMTI stock is "Strong Buy." The 12-month stock price forecast is $48.5, which is an increase of 65.42% from the latest price.
Stock Forecasts
2 months ago · seekingalpha.com
Sanara MedTech: A Promising Growth Story At An Attractive ValuationShares have risen nearly 15% since the company posted preliminary Q4 results, which showed revenue up by 45-48% year over year. While growth was boosted by one-off demand for its BIASURGE product, und...